Bellicum Announces Data Presentations on Lead Product Candidate Rivo-cel and Controllable CAR Program at the 60th American Society of Hematology Annual Meeting Read more about Bellicum Announces Data Presentations on Lead Product Candidate Rivo-cel and Controllable CAR Program at the 60th American Society of Hematology Annual Meeting
Bellicum Pharmaceuticals to Participate in Two Healthcare Investor Conferences in September Read more about Bellicum Pharmaceuticals to Participate in Two Healthcare Investor Conferences in September
Bellicum Pharmaceuticals Reports Second Quarter 2018 Financial Results Read more about Bellicum Pharmaceuticals Reports Second Quarter 2018 Financial Results
Bellicum Pharmaceuticals Appoints Dr. Thierry Darcis as General Manager of Europe to Lead the Anticipated Launch of BPX-501 Read more about Bellicum Pharmaceuticals Appoints Dr. Thierry Darcis as General Manager of Europe to Lead the Anticipated Launch of BPX-501
Bellicum Pharmaceuticals to Report Second Quarter 2018 Financial Results and Host Conference Call and Webcast on August 7, 2018 Read more about Bellicum Pharmaceuticals to Report Second Quarter 2018 Financial Results and Host Conference Call and Webcast on August 7, 2018
Bellicum Pharmaceuticals Announces Departure of Chief Financial Officer Read more about Bellicum Pharmaceuticals Announces Departure of Chief Financial Officer
Bellicum Pharmaceuticals to Present at the Jefferies 2018 Global Healthcare Conference Read more about Bellicum Pharmaceuticals to Present at the Jefferies 2018 Global Healthcare Conference
Bellicum Pharmaceuticals Appoints Shane Ward as General Counsel Read more about Bellicum Pharmaceuticals Appoints Shane Ward as General Counsel
Bellicum Announces Clinical Presentations on Lead Product Candidate BPX-501 at the 23rd Congress of the European Hematology Association Read more about Bellicum Announces Clinical Presentations on Lead Product Candidate BPX-501 at the 23rd Congress of the European Hematology Association
Bellicum Announces Oral Presentation on Dual-Switch CAR-T Technology at the 21st Annual Meeting of the American Society of Gene and Cell Therapy Read more about Bellicum Announces Oral Presentation on Dual-Switch CAR-T Technology at the 21st Annual Meeting of the American Society of Gene and Cell Therapy